PHG Stock Analysis: Buy, Sell, or Hold?
PHG - KONINKLIJKE PHILIPS N.V.
$26.68
-0.30 (-1.13%)
▼
5d:
-0.06%
30d:
-1.75%
90d:
-0.5%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 28, 2026
Get Alerted When PHG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PHG shows positive signals but monitor for confirmation. Market pricing in 2.6% decline. Moderate conviction.
💡 BUY OPPORTUNITY: PHG shows positive signals but monitor for confirmation. Market pricing in 2.6% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$43.18
Based on 8.2% avg growth
INTRINSIC VALUE TODAY
$26.81
0.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PHG is currently trading at $26.68, which is considered extended relative to its 30-day fair value range of $25.74 to $26.80. The stock's valuation (Forward PE: 13.2) is in line with its historical norms (14.3). Remarkably, the market is currently pricing in an annual earnings decline of 2.6% over the next few years. This pessimistic expectation contrasts with the company's recent 97.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PHG is in a strong downtrend. The price is approaching resistance at $27.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PHG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.54 (+24.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PHG is in a strong downtrend. The price is approaching resistance at $27.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PHG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.54 (+24.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$25.74 -
$26.80
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.3% below Wall St target ($33.54)
Trading Range Analysis
30-Day Trading Range
$25.74 -
$26.80
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$25.56
Resistance Level
$27.27
Current Trend
Strong Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.22
Wall Street Target
$33.54
(+24.3%)
Revenue Growth (YoY)
-4.7%
Earnings Growth (YoY)
97.2%
Profit Margin
5.5%
Valuation Discount vs History
-2.6% cheaper
PE vs Historical
13.2 vs 14.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.6%
(market-implied from PE analysis)
1-Year Target
$26.28
(-3%)
2-Year Target
$25.60
(-5%)
3-Year Target
$24.93
(-8%)
3-Yr Target (if PE normalizes)
(PE: 13→14)
$26.96
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 12.4%)
$63.09
(+134%)
Base:
(SPY PE: 13.2, Growth: 12.4%)
$38.31
(+42%)
Bear:
(PE: 11.2, Growth: 12.4%)
$32.56
(+21%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 23.09 | Current EPS (TTM): $1.16
Bull Case
$51.81
(+92%)
Analyst growth 75.9%, PE expands to 25.4
Base Case
$47.10
(+75%)
Market implied 75.9%, PE stable at 23.1
Bear Case
$18.21
(-33%)
Severe decline -20.0%, PE contracts to 19.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.2 to 14.3
Stabilization Target:
$29.17
(+8.1%)
PE Expansion Potential:
+8.1%
Share & Embed Analysis
Last updated: June 23, 2026 12:59 PM ET
Data refreshes hourly during market hours. Next update: 1:59 PM
Data refreshes hourly during market hours. Next update: 1:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 57 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 61 BUY |
